Lymphocyte–C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission

In this study, we aimed to explore whether lymphocyte–C-reactive protein ratio (LCR) can differentiate disease severity of coronavirus disease 2019 (COVID-19) patients and its value as an assistant screening tool for admission to hospital and intensive care unit (ICU). A total of 184 adult COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian-Nan, Gao, Yang, Wang, Xin-Tong, Li, Na-Na, Du, Xue, Tang, Yu-Jia, Lai, Qi-Qi, Chen, Peng-Fei, Yue, Chuang-Shi, Wu, Ji-Han, Kang, Kai, Zhao, Ming-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554799/
https://www.ncbi.nlm.nih.gov/pubmed/36248811
http://dx.doi.org/10.3389/fimmu.2022.957407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554799/
https://www.ncbi.nlm.nih.gov/pubmed/36248811
http://dx.doi.org/10.3389/fimmu.2022.957407

Ejemplares similares